These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33396965)

  • 1. Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens.
    Al-Ishaq RK; Skariah S; Büsselberg D
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
    El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
    Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
    Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
    Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria.
    Latz S; Wahida A; Arif A; Häfner H; Hoß M; Ritter K; Horz HP
    J Basic Microbiol; 2016 Oct; 56(10):1117-1123. PubMed ID: 27194637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage therapy for severe bacterial infections: a narrative review.
    Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
    Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of phage application in bacterial decolonisation: a systematic review.
    Fang Q; Yin X; He Y; Feng Y; Zhang L; Luo H; Yin G; McNally A; Zong Z
    Lancet Microbe; 2024 May; 5(5):e489-e499. PubMed ID: 38452780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental mouse model for phage therapy of bacterial pathogens causing bacteremia.
    Kaabi SAG; Musafer HK
    Microb Pathog; 2019 Dec; 137():103770. PubMed ID: 31586662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages: A Therapy Concept against Multi-Drug-Resistant Bacteria.
    Rohde C; Wittmann J; Kutter E
    Surg Infect (Larchmt); 2018; 19(8):737-744. PubMed ID: 30256176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.
    Chadha P; Katare OP; Chhibber S
    Microb Pathog; 2016 Oct; 99():68-77. PubMed ID: 27498362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback?
    Hill C; Mills S; Ross RP
    Future Microbiol; 2018 May; 13():711-726. PubMed ID: 29792526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies.
    Liu D; Van Belleghem JD; de Vries CR; Burgener E; Chen Q; Manasherob R; Aronson JR; Amanatullah DF; Tamma PD; Suh GA
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.